HIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling

被引:38
|
作者
Masci, AM
Galgani, M
Cassano, S
De Simone, S
Gallo, A
De Rosa, V
Zappacosta, S
Racioppi, L
机构
[1] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy
[2] Ist Endocrinol & Oncol Sperimentale, Naples, Italy
关键词
CXCR4; HIVenv; cAMP; CREB;
D O I
10.1189/jlb.0503239
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The ability of the envelope glycoprotein gp120 [human immunodeficiency virus (HIV) env] to induce intracellular signals is thought to contribute to HIV-1 pathogenesis. In the present study, we found that the exposure of CD4+ CD45RA+ naive T cells to HIVenv results in a long-lasting hyporesponsiveness to antigen stimulation. This phenomenon is not dependent on CD4-mediated signals and also can be generated by the exposure of naive T cell to soluble CD4-HIVenv complexes. The analysis of the proximal signaling reveals that HIVenv does not activate Lck as well as the mitogen-activated protein kinase intermediate cascade. Conversely, the envelope glycoprotein stimulates the cyclic adenosine monophosphate (cAMP)-dependent protein kinase A (PKA) activity and induces the progressive accumulation of the phosphorylated form of the cAMP-responsive element binding. Of note, the ligation of CXCR4 by stromal cell-derived factor-1alpha but not the engagement of CD4 by monoclonal antibody stimulates the PKA activity and induces a long-lasting hyporesponsivity state in naive CD4+ lymphocytes. The pretreatment of lymphocytes with 1189, a cell-permeable PKA inhibitor, prevents the induction of anergy. These findings reveal a novel mechanism by which HIVenv may modulate the processes of clonal expansion, homeostatic proliferation, and terminal differentiation of the naive T lymphocyte subset.
引用
收藏
页码:1117 / 1124
页数:8
相关论文
共 50 条
  • [21] HIV-1 gp120 induces an association between CD4 and the chemokine receptor CXCR4
    Ugolini, S
    Moulard, M
    Mondor, I
    Barois, N
    Demandolx, D
    Hoxie, J
    Brelot, A
    Alizon, M
    Davoust, J
    Sattentau, QJ
    JOURNAL OF IMMUNOLOGY, 1997, 159 (06): : 3000 - 3008
  • [22] SENSITIZATION OF T-CELLS TO CD95-MEDIATED APOPTOSIS BY HIV-1 TAT AND GP120
    WESTENDORP, MO
    FRANK, R
    OCHSENBAUER, C
    STRICKER, K
    DHEIN, J
    WALCZAK, H
    DEBATIN, KM
    KRAMMER, PH
    NATURE, 1995, 375 (6531) : 497 - 500
  • [23] HIV-1 induces cardiomyopathy by cardiomyocyte invasion and gp120, tat, and cytokine apoptotic signaling
    Milan Fiala
    Waldemar Polik
    Jian-Hua Qiao
    Albert S. Lossinsky
    Timothy Alce
    Kenix Tran
    Wendy Yang
    Kenneth P. Roos
    James Arthos
    Cardiovascular Toxicology, 2004, 4 (2) : 97 - 107
  • [24] HIV-1 ENVELOPE PROTEIN GP120 PROMOTES ACTIVATION OF PROTEIN SYNTHESIS IN GLIOMAS THROUGH THE ERK AND AKT SIGNALING
    Valentin-Guillama, Gabriel
    Kucheryavykh, Yuriy
    Kucheryavykh, Lilia
    NEURO-ONCOLOGY, 2018, 20 : 51 - 52
  • [25] Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+T cells, mediated via cell signaling and Tat cofactor overexpression
    Missé, D
    Gajardo, J
    Oblet, C
    Religa, A
    Riquet, N
    Mathieu, D
    Yssel, H
    Veas, F
    AIDS, 2005, 19 (09) : 897 - 905
  • [26] Antibody interrogation of the CD4-bound conformation of HIV-1 gp120
    Gershoni, Jonathan
    Lewis, George
    Kaplan, Gilad
    Roitburd-Berman, Anna
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 67 : 58 - 58
  • [27] Allosteric induction of the CD4-bound conformation of HIV-1 Gp120
    Roitburd-Berman, Anna
    Dela, Gal
    Kaplan, Gilad
    Lewis, George K.
    Gershoni, Jonathan M.
    RETROVIROLOGY, 2013, 10
  • [28] Allosteric induction of the CD4-bound conformation of HIV-1 Gp120
    Anna Roitburd-Berman
    Gal Dela
    Gilad Kaplan
    George K Lewis
    Jonathan M Gershoni
    Retrovirology, 10
  • [29] PHOSPHOROTHIOATE OLIGODEOXYCYTIDINE INTERFERES WITH BINDING OF HIV-1 GP120 TO CD4
    STEIN, CA
    NECKERS, LM
    NAIR, BC
    MUMBAUER, S
    HOKE, G
    PAL, R
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1991, 4 (07) : 686 - 693